Organizer
Location
AACSM Webinar
Topic: Narcolepsy Reimagined: Innovations in Diagnosis and Management
Format: Interactive and Discussion
Cost: Complimentary
Date: Tuesday, November 17, 2026
Time: 7:30PM Eastern Time
Learning Objectives:
-
- Recognize the clinical manifestations and diagnostic challenges of narcolepsy types 1 and 2, including factors contributing to delayed or missed diagnosis.
- Evaluate emerging diagnostic approaches and biomarkers for narcolepsy, including advances in sleep testing, cerebrospinal fluid hypocretin assessment, and novel diagnostic technologies.
- Develop evidence-based, patient-centered management plans that address excessive daytime sleepiness, cataplexy, disrupted nighttime sleep, and long-term quality of life.
- Compare current and emerging pharmacologic treatments for narcolepsy, with emphasis on novel mechanisms of action, orexin receptor agonists, and individualized treatment strategies.
Group Viewing Notice: If multiple participants plan to view this session from the same location (e.g., a group practice or shared workspace), each individual must register separately to be eligible for CME or CSTE credit and a certificate of completion. This ensures accurate participation tracking for evaluations, credit alignment, and CME/CSTE reporting compliance.
Closed captioning for this program will be available.
About the Presenter: Alon Y. Avidan, MD, MPH, FAAN, FAASM
Dr. Avidan is Professor of Neurology at the David Geffen School of Medicine at UCLA and Director Emeritus of the UCLA Sleep Disorders Center. He is a nationally and internationally recognized neurologist, sleep medicine specialist, researcher, and educator with over 30 years of clinical and academic experience. He completed his Neurology residency at Georgetown University Medical Center and Sleep Medicine fellowship at the Cleveland Clinic. He is a Fellow of the American Academy of Neurology and the American Academy of Sleep Medicine and is board-certified in Neurology and Sleep Medicine.
Dr. Avidan’s clinical and research interests focus on the relationship between sleep disorders and neurological disease, particularly REM sleep behavior disorder (RBD) as an early marker of neurodegenerative conditions. His work explores the impact of sleep disturbances on neurological function, cognition, and disease progression. Since 2021, his research has been supported by the Toffler Charitable Trust, and in 2024, he was named an Endowed Toffler Scholar in recognition of his distinguished research contributions to sleep medicine.
A dedicated educator and prolific scholar, Dr. Avidan received the 2014 American Academy of Sleep Medicine Excellence in Education Award for his career contributions to sleep medicine education. He also served as Visiting Professor of Neurology Education at the Mayo Clinic College of Medicine in Rochester, Minnesota. He has made significant contributions to the scientific literature in sleep medicine and neurology and coauthored four textbooks, including Handbook of Sleep Medicine, Geriatric Sleep Medicine, Review of Sleep Medicine, and Atlas of Clinical Sleep Medicine. His career reflects a sustained commitment to advancing clinical care, scientific discovery, and education in sleep medicine and neurology.
